Abstract
Knowledge regarding the anatomical organization of neurotransmitter systems is thought to be critical to understanding the basis of brain function and the action of many drugs. At a first approximation, the anatomical organization of nerve terminals that release excitatory amino acids (EAAs) appears quite simple. Most synapses in the vertebrate CNS that display fast, excitatory transmission probably use an EAA as their neurotransmitter; most synapses that display inhibitory or primarily modulatory transmission do not use an EAA neurotransmitter. Within this simple, ubiquitous distribution of EAA pathways, however, there appears to be a complex organization of multiple, distinct subsystems which differ in their composition of EAA receptors. Since EAA receptor subtypes differ in their physiological and pharmacological properties, as well as their anatomical distributions, the corresponding EAA pathways can be thought of as functionally and pharmacologically distinct EAA systems. Furthermore, in addition to this level of complexity, recent studies have shown that individual EAA receptor types can represent multiple isoforms that can differ in function [1]. Thus, there is considerable potential for both functional and pharmacological diversity which may have many implications for understanding brain function and developing therapeutic agents.
This work was supported by NIH grant NS 28966 and by the Eli Lilly Co.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sommer B, Keinänen K, Verdoom TA, Wisden W, Burnashev N, Herb A, Köhler M, Takagi T, Sakmann B, Seeburg PH (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249: 1580–1585
Collingridge GL, Lester RAJ (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 40: 143–210
Monaghan DT, Bridges RJ, Cotman CW (1989) The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29: 365–402
Watkins JC, Krogsgaard-Larsen P, Honoré T (1990) Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci 11: 25–33
Boulter J, Hollmann M, O’Shea-Greenfield A, Hartley M, Deneris E, Maron C, Heinemann S (1990) Molecular cloning and functional expression of glutamate receptor subunit genes. Science 249: 1033–1037
Keinänen K, Wisden, W, Sommer, B, Werner P, Herb A, Verdoorn TA, Sakmann B, Seeburg PH (1990) A family of AMPA-selective glutamate receptors. Science 249: 556–560
Werner P, Voigt M, Keinänen K, Wisden W, Seeburg PH (1991) Cloning of a putative high-affinity kainate receptor expressed predominately in hippocampal CA3 cells. Nature 351: 742–744
Egebjerg J, Bettler B, Hermans-Borgmeyer I, Heinemann S (1991) Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not by AMPA. Nature 351: 745–748
Cotman CW, Bridges RJ, Taube JS, Clark AS, Geddes JW, Monaghan DT (1989) The role of the NMDA receptor in central nervous system plasticity and pathology. J NIH Res 1: 65–74
Rauschecker JP (1991) Mechanisms of visual plasticity: Hebb synapses, NMDA receptors, and beyond. Physiol Rev 71: 587–615
Monaghan DT, Anderson KJ (1991) Heterogeneity and organizaton of excitatory amino acid receptors and transporters. In: Wheal H, Thomson A (eds) Excitatory amino acids and synaptic function. Academic, London, pp 33–54
Fagg GE, Matus A (1984) Selective association of N-methyl aspartate and quisqualate types of L-glutamate receptor with brain postsynaptic densities. Proc Natl Acad Sci USA 81: 6876–6880
Monaghan DT, Cotman CW (1986) Identification and properties of NMDA receptors in rat brain synaptic plasma membranes. Proc Natl Acad Sci USA 83: 7532–7536
Monaghan DT, Cotman CW (1985) Distribution of NMDA-sensitive L-3H-glutamate binding sites in rat brain as determined by quantitative autoradiography. J Neurosci 5: 2909–2919
Maragos WF, Penney JB, Young AB (1988) Anatomic correlation of NMDA and [H]TCP-labelled receptors in rat brain. J Neurosci 8: 493–501
Harris EW, Cotman CW (1986) Long-term potentiation of guinea pig mossy fiber responses in not blocked by N-methyl-D-aspartate antagonists. Neurosci Lett 70: 132–137
Crepel F, Ahanjal SS, Sears TA (1982) Effect of glutamate, aspartate, and related derivatives on cerebellar Purkinje cell dendrites in the rat: an in vitro study. J Physiol (Lond) 329: 297–317
Fagg GE, Foster AC (1983) Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 9: 701–719
Fonnum F (1984) Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42: 1–11
Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J (1987) Anatomical organization of excitatory amino acid receptors and their pathways Trends Neuro-sci 10: 273–280
Mayer ML, Westbrook GL (1987) The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28: 197–276
Monaghan DT, Cotman CW (1986) Anatomical organization of NMDA, kainate and quisqualate receptors. In: Roberts PJ, Storm-Mathisen J, Bradford H (eds) Excitatory amino acids. Macmillan Press, London, pp 279–299
Rassendren F-A, Lory P, Pin J-P, Bockaert J, Nargeot J (1989) A specific quisqualate agonist inhibits kainate responses induced in Xenopus oocytes injected with rat brain RNA. Neurosci Lett 99: 333–339
Zorumski CF, Yang J (1988) AMPA, kainate, and quisqualate activate a common receptor-channel complex on embryonic chick motorneurons. J Neurosci 8: 42774286
Wroblewski JT, Danysz W (1989) Modulation of glutamate receptors: molecular mechanisms and functional implications. Annu Rev Pharmacol Toxicol 29: 441474
Young AB, Fagg GE (1990) Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol Sci 11: 126–133
Trombley P, Westbrook G (1990) L-AP4 reduces high threshold calcium currents in olfactory bulb neurons. Soc Neurosci Abstr 16: 547
Schoepp D, Bockaert J, Sladeczek F (1990) Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors. Trends Pharmacol Sci 11: 508–515
Cotman CW, Flatman JA, Ganong AH, Perkins MN (1986) Effects of excitatory amino-acid antagonists on evoked and spontaneous excitatory potentials in guinea-pig hippocampus. J Physiol (Lond) 378: 403–415
Brose N, Thomas A, Weber MG, Jahn R (1990) A chloride-and calcium-dependent glutamate binding protein from rat brain. Identification as a ubiquitous constituent of the inner mitochondrial membrane. J Biol Chem 265: 10604–10610
Koerner JF, Cotman CW (1981) Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex. Brain Res 216: 192–198
Lanthorn TH, Ganong AH, Cotman CW (1984) 2-Amino-4-phosphonobutyrate selectively blocks mossy fiber-CA3 responses in guinea pig but not rat hippo-campus. Brain Res 290: 174–178
Yamamoto C, Sawada S, Takada S (1983) Suppressing action of 2-amino-4-phosphonobutyric acid on mossy fiber-induced excitation in the guinea pig hippo-campus. Exp Brain Res 51: 128–134
Slaughter MM, Miller RF (1981) 2-Amino-4-phosphonobutyric acid: a new pharmacological tool for retina research. Nature 211: 182–185
Collins GGS (1982) Some effects of excitatory amino acid receptor antagonists on synaptic transmission in the rat olfactory cortex slice. Brain Res 244: 311–318
Davies J, Watkins JC (1982) Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Res 235: 378–386
Hwang PM, Bredt DS, Snyder SH (1990) Autoradiographic imaging of phosphoinositide turnover in the brain. Science 249: 802–804
Cha JJ, Makowiec RL, Penney JB, Young AB (1990) L-[3H]Glutamate labels the metabotropic excitatory amino acid receptor in rodent brain. Neurosci Lett 113: 78–83
Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S (1991) Sequence and expression of a metabotropic glutamate receptor. Nature 349: 760–765
Olverman HJ, Monaghan DT, Cotman CW, Watkins JC (1986) [3H]CPP, a new competitive ligand for NMDA receptors. Eur J Pharmacol 131: 161–162
Monaghan DT, Olverman HJ, Nguyen L, Watkins JC, Cotman CW (1988) Two classes of NMDA recognition sites: differential distribution and differential regulation by glycine. Proc Natl Acad Sci USA 85: 9836–9840
Monaghan DT, Yao D, Olverman HJ, Watkins JC, Cotman CW (1984) Autoradiography of D-[3H]2-amino-5-phosphonopentanoate binding sites in rat brain. Neurosci Lett 52: 253–258
Monaghan DT (1991) Differential stimulation of [3H]MK-801 binding to sub-populations of NMDA receptors. Neurosci Lett 122: 21–24
Monaghan DT, Beaton JA (1991) Quinolinate differentiates between cerebellar and forebrain NMDA receptors. Eur J Pharmacol 194: 123–125
Monaghan DT, Beaton JA (1991) Pharmacologically-distinct NMDA receptor subtypes. Soc Neurosci Abstr 17: 75
Reynolds IJ, Palmer AM (1991) Regional variations in [3H]MK801 binding to rat brain N-methyl-D-aspartate receptors. J Neurochem 56: 1731–1740
Yoneda Y, Ogita K, Enomoto R (1991) Characterization of spermidine-dependent [3H1(+)-5-methyl-I0,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK- 801) binding in brain synaptic membranes treated with Triton X-100. J Pharmacol Exp Ther 256: 1161–1172
O’Shea RD, Manallack DT, Conway EL, Mercer LD, Beart PM (1991) Evidence for heterogenous glycine domains but conserved multiple states of the excitatory amino acid recognition site of the NMDA receptor: regional binding studies with [3H]glycine and [3H]t,-glutamate. Exp Brain Res 86: 652–662
Vignon J, Privat A, Chaudieu I, Thierry A, Kamenka JM, Chicheportiche R (1986) [3H]Thienyl-phencyclidine ([3H]TCP) binds to two different sites in rat brain. Localizaton by autoradiography and biochemical techniques. Brain Res 378: 133–141
Quarum M, Parker JD, Keana JEW, Weber E (1990) (+)-[3H]MK-801 binding sites in postmortem human brain. J Neurochem 54: 1163–1168
Sircar R, Zukin SR (1985) Quantitative localization of [3H]TCP binding in rat brain by light microscopic autoradiography. Brain Res 344: 142–145
Jarvis MF, Murphy DE, Williams M (1987) Q3 antitative autoradiographic localization of NMDA receptors in rat brain using [H]CPP: comparison with [3H]TCP binding sites. Eur J Pharmacol 141: 149–152
Sekiguchi M, Okamoto K, Sakai Y (1990) Glycine-insensitive NMDA-sensitive receptor expressed in Xenopus oocytes by guinea pig cerebellar mRNA. J Neuro-sci 10: 2148–2155
Perkins MN, Stone TW (1983) Quinolinic acid: regional variations in neuronal sensitivity. Brain Res 259: 172–176
Perkins MN, Stone TW (1983) Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system. J Pharmacol Exp Ther 226: 551–557
D’ Angelo E, Rossi P, Garthwaite J (1990) Dual-component NMDA receptor currents at a single central synapse. Nature 346: 467–470
Zeevalk GD, Nicklas WJ (1990) Action of the anti-ischemic agent ifenprodil on Nmethyl-D-aspartate and kainate-mediated excitotoxicity. Brain Res 522: 135–139
Ornstein PL, Schoepp DD, Leander JD, Lodge D (1991) The development of novel competitive NMDA antagonists as useful therapeutic agents. Discovery of LY 274614 and LY 233536. In: Meldrum BS, Moroni F, Simon RP, Woods JH (eds) Excitatory amino acids. Raven, New York, pp 415–423
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Monaghan, D.T., Beaton, J.A. (1991). Diversity and Organization of Excitatory Amino Acid Receptors in the CNS. In: Teichberg, V.I., Turski, L. (eds) Excitatory Amino Acids and Second Messenger Systems. Schering Foundation Workshop, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22666-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-22666-7_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-22668-1
Online ISBN: 978-3-662-22666-7
eBook Packages: Springer Book Archive